BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35319525)

  • 21. Primary mucoepidermoid carcinoma of the liver with CRTC1-MAML2 fusion: a case report.
    Watanabe J; Kai K; Tanikawa K; Hiraki M; Mizukami N; Aishima S; Nakano T; Yamamoto H
    Diagn Pathol; 2019 Jul; 14(1):84. PubMed ID: 31351495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MAML2 gene rearrangement, fusion patterns and clinicopathological characteristics in primary pulmonary mucoepidermoid carcinoma].
    Zhang X; Bai QM; Yao QL; Ji G; Chang H; Han J; Li Y; Ji Y; Hou YY; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):891-898. PubMed ID: 34344072
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary mucoepidermoid carcinoma of the external auditory canal with a CRTC1::MAML2 fusion: A case report and a review of literature.
    De la Sancha C; Kuhar M; Kraft A; Alomari AK
    J Cutan Pathol; 2023 Nov; 50(11):947-950. PubMed ID: 37394842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma.
    Jee KJ; Persson M; Heikinheimo K; Passador-Santos F; Aro K; Knuutila S; Odell EW; Mäkitie A; Sundelin K; Stenman G; Leivo I
    Mod Pathol; 2013 Feb; 26(2):213-22. PubMed ID: 23018873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus.
    Roden AC; Erickson-Johnson MR; Yi ES; García JJ
    Hum Pathol; 2013 Dec; 44(12):2799-805. PubMed ID: 24134933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
    Fehr A; Meyer A; Heidorn K; Röser K; Löning T; Bullerdiek J
    Genes Chromosomes Cancer; 2009 Sep; 48(9):777-85. PubMed ID: 19521953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative radiotherapy for T1/2N0M0 mucoepidermoid carcinoma positive for CRTC1/3-MAML2 fusions.
    Okumura Y; Murase T; Saida K; Fujii K; Takino H; Masaki A; Ijichi K; Shimozato K; Tada Y; Nibu KI; Inagaki H
    Head Neck; 2018 Dec; 40(12):2565-2573. PubMed ID: 30475407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomics and tumor microenvironment of breast mucoepidermoid carcinoma based on whole-exome and RNA sequencing.
    Ge Y; Lin X; He J; Chen W; Lin D; Zheng Y; Yang L; Xu F; Li Z
    Diagn Pathol; 2024 Jan; 19(1):15. PubMed ID: 38243319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells.
    Chen J; Li JL; Chen Z; Griffin JD; Wu L
    BMC Cancer; 2015 Oct; 15():803. PubMed ID: 26503699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.
    Tirado Y; Williams MD; Hanna EY; Kaye FJ; Batsakis JG; El-Naggar AK
    Genes Chromosomes Cancer; 2007 Jul; 46(7):708-15. PubMed ID: 17437281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast.
    Bean GR; Krings G; Otis CN; Solomon DA; García JJ; van Zante A; Camelo-Piragua S; van Ziffle J; Chen YY
    Histopathology; 2019 Feb; 74(3):463-473. PubMed ID: 30380176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
    Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
    Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
    O'Neill ID
    Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Profiling of Salivary Oncocytic Mucoepidermoid Carcinomas Helps to Resolve Differential Diagnostic Dilemma With Low-grade Oncocytic Lesions.
    Skálová A; Agaimy A; Stanowska O; Baneckova M; Ptáková N; Ardighieri L; Nicolai P; Lombardi D; Durzynska M; Corcione L; Laco J; Koshyk O; Žalud R; Michal M; Vanecek T; Leivo I
    Am J Surg Pathol; 2020 Dec; 44(12):1612-1622. PubMed ID: 33002921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clear cell variant of mucoepidermoid carcinoma harboring CRTC1-MAML2 fusion gene found in buccal mucosa: report of a case showing a large clear cell component and lacking typical epidermoid cells and intermediate cells.
    Tajima S; Namiki I; Koda K
    Med Mol Morphol; 2017 Jun; 50(2):117-121. PubMed ID: 26297211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Grade Transformation in Mucoepidermoid Carcinoma of the Minor Salivary Gland with Polyploidy of the Rearranged MAML2 Gene.
    Lee H; Roh JL; Choi YJ; Choi J; Cho KJ
    Head Neck Pathol; 2020 Sep; 14(3):822-827. PubMed ID: 31535311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.
    Nakano T; Yamamoto H; Hashimoto K; Tamiya S; Shiratsuchi H; Nakashima T; Nishiyama K; Higaki Y; Komune S; Oda Y
    Histopathology; 2013 Sep; 63(3):378-92. PubMed ID: 23855785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAML2 rearrangement in primary pulmonary mucoepidermoid carcinoma and the correlation with FLT1 expression.
    Zhu F; Wang W; Hou Y; Shi J; Liu Z; He D; Bai C; Li S; Jiang L
    PLoS One; 2014; 9(4):e94399. PubMed ID: 24714697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.
    Lennerz JK; Perry A; Dehner LP; Pfeifer JD; Lind AC
    Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.
    Okabe M; Miyabe S; Nagatsuka H; Terada A; Hanai N; Yokoi M; Shimozato K; Eimoto T; Nakamura S; Nagai N; Hasegawa Y; Inagaki H
    Clin Cancer Res; 2006 Jul; 12(13):3902-7. PubMed ID: 16818685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.